TickerFactsScreenerDevelopers

NEKTAR THERAPEUTICS (NKTR) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $16.39M2010: $31.46M2011: $9.72M2012: $10.58M2013: $4.09M2014: $9.98M2015: $11.20M2016: $6.39M2017: $9.68M2018: $14.24M2019: $26.29M2020: $7.26M2021: $14.99M2022: $5.68M2023: $865.0K2024: $1.47M2025: $171.0K$171.0K
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$171.0K-88.4%
2024$1.47M+69.7%
2023$865.0K-84.8%
2022$5.68M-62.1%
2021$14.99M+106.5%
2020$7.26M-72.4%
2019$26.29M+84.6%
2018$14.24M+47.2%
2017$9.68M+51.4%
2016$6.39M-42.9%
2015$11.20M+12.2%
2014$9.98M+143.9%
2013$4.09M-61.3%
2012$10.58M+8.9%
2011$9.72M-69.1%
2010$31.46M+91.9%
2009$16.39M—